ROTOP Radiopharmacy

ROTOP Radiopharmacy, officially ROTOP Pharmaka GmbH, is a specialized pharmaceutical company focused on the development, production, and global distribution of radiopharmaceuticals for diagnostic imaging and therapy. Based in Dresden, Germany, the company maintains a robust portfolio of SPECT and PET products, including Technetium-99m cold kits and various tracers for oncology and cardiology. In addition to its proprietary product line, ROTOP serves as a high-tech Contract Development and Manufacturing Organization (CDMO) for radioactive medicinal products. The company was acquired by Curium in 2021, integrating its specialized manufacturing capabilities into one of the world's largest radiopharmaceutical networks. ROTOP continues to play a critical role in the supply chain for nuclear medicine across Europe and international markets.